Rare diseases
Investigational molecules
Locations
Study on the Long-Term Safety of Bepranemab for Adults with Progressive Supranuclear Palsy
GermanyStudy on Long-term Safety of VX-121, Tezacaftor, and Deutivacaftor in Patients with Cystic Fibrosis
GermanyStudy of Cemiplimab Compared to Placebo After Surgery and Radiation for Patients with High-Risk Skin Squamous Cell Carcinoma
GermanyStudy on the Effectiveness and Safety of Crovalimab vs. Eculizumab for Adults and Adolescents with Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Treated with Complement Inhibitors
GermanyStudy on Vimseltinib for Patients with Tenosynovial Giant Cell Tumor
GermanyStudy on Personalized Treatment for Post-Pubertal Patients with Newly Diagnosed Medulloblastoma Using Sonidegib, Cisplatin, Lomustine, and Vincristine
GermanyStudy of Lurbinectedin and Atezolizumab for Maintenance Therapy in Patients with Extensive-Stage Small-Cell Lung Cancer
GermanyStudy on Ravulizumab for Adults with Immunoglobulin A Nephropathy (IgAN) to Preserve Kidney Function
GermanyStudy on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis
GermanyStudy on the Safety and Tolerability of Teprotumumab for Patients with Thyroid Eye Disease
GermanyStudy on CTL-002 and Nivolumab for Patients with Advanced-Stage, Relapsed/Refractory Solid Tumors
GermanyStudy of inavolisib, palbociclib and fulvestrant in patients with PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced or metastatic breast cancer
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
